These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10668712)

  • 1. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging.
    Rockwood K; Wentzel C; Hachinski V; Hogan DB; MacKnight C; McDowell I
    Neurology; 2000 Jan; 54(2):447-51. PubMed ID: 10668712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and institutionalization in early survivors of stroke: the effects of cognition, vascular mild cognitive impairment, and vascular dementia.
    Brodaty H; Altendorf A; Withall A; Sachdev PS
    J Stroke Cerebrovasc Dis; 2010; 19(6):485-93. PubMed ID: 20538487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study.
    Avila-Funes JA; Amieva H; Barberger-Gateau P; Le Goff M; Raoux N; Ritchie K; Carrière I; Tavernier B; Tzourio C; Gutiérrez-Robledo LM; Dartigues JF
    J Am Geriatr Soc; 2009 Mar; 57(3):453-61. PubMed ID: 19245415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in elderly Canadians with and without dementia: a 5-year follow-up.
    Ostbye T; Hill G; Steenhuis R
    Neurology; 1999 Aug; 53(3):521-6. PubMed ID: 10449114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons.
    Maxwell CJ; Hogan DB; Ebly EM
    Dement Geriatr Cogn Disord; 2002; 13(4):225-34. PubMed ID: 12006733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of cognitive impairment with no dementia.
    Tuokko H; Frerichs R; Graham J; Rockwood K; Kristjansson B; Fisk J; Bergman H; Kozma A; McDowell I
    Arch Neurol; 2003 Apr; 60(4):577-82. PubMed ID: 12707072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and severity of cognitive impairment with and without dementia in an elderly population.
    Graham JE; Rockwood K; Beattie BL; Eastwood R; Gauthier S; Tuokko H; McDowell I
    Lancet; 1997 Jun; 349(9068):1793-6. PubMed ID: 9269213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of positive screening test for cognitive impairment among elderly urogynecologic patients.
    Trowbridge ER; Kim D; Barletta K; Fitz V; Larkin S; Hullfish KL
    Am J Obstet Gynecol; 2016 Nov; 215(5):663.e1-663.e6. PubMed ID: 27319369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment, degenerative and vascular dementia as predictors of intra-hospital, short- and long-term mortality in the oldest old.
    Zekry D; Herrmann FR; Graf CE; Giannelli S; Michel JP; Gold G; Krause KH
    Aging Clin Exp Res; 2011 Feb; 23(1):60-6. PubMed ID: 21499020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the prevalence of and modifiable risk factors for cognitive impairment among community-dwelling Canadian seniors over two decades, 1991-2009.
    Chireh B; D'Arcy C
    PLoS One; 2020; 15(12):e0242911. PubMed ID: 33326422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Place of death and end-of-life transitions experienced by very old people with differing cognitive status: retrospective analysis of a prospective population-based cohort aged 85 and over.
    Perrels AJ; Fleming J; Zhao J; Barclay S; Farquhar M; Buiting HM; Brayne C;
    Palliat Med; 2014 Mar; 28(3):220-33. PubMed ID: 24317193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment.
    Fisk JD; Merry HR; Rockwood K
    Neurology; 2003 Nov; 61(9):1179-84. PubMed ID: 14610117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of impairment in patients with vascular cognitive impairment without dementia.
    Wentzel C; Rockwood K; MacKnight C; Hachinski V; Hogan DB; Feldman H; Østbye T; Wolfson C; Gauthier S; Verreault R; McDowell I
    Neurology; 2001 Aug; 57(4):714-6. PubMed ID: 11524488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: a 3-year follow-up study.
    Zanetti M; Ballabio C; Abbate C; Cutaia C; Vergani C; Bergamaschini L
    J Am Geriatr Soc; 2006 Apr; 54(4):580-6. PubMed ID: 16686866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More than the epidemiology of Alzheimer's disease: contributions of the Canadian Study of Health and Aging.
    Lindsay J; Sykes E; McDowell I; Verreault R; Laurin D
    Can J Psychiatry; 2004 Feb; 49(2):83-91. PubMed ID: 15065741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment.
    Rockwood K; Ebly E; Hachinski V; Hogan D
    Arch Neurol; 1997 Jan; 54(1):33-9. PubMed ID: 9006411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical vascular cognitive impairment and Alzheimer disease: neuropsychological test performance 5 years before diagnosis.
    Ingles JL; Boulton DC; Fisk JD; Rockwood K
    Stroke; 2007 Apr; 38(4):1148-53. PubMed ID: 17322075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging.
    Ebly EM; Parhad IM; Hogan DB; Fung TS
    Neurology; 1994 Sep; 44(9):1593-600. PubMed ID: 7936280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian study of health and aging: study methods and prevalence of dementia.
    CMAJ; 1994 Mar; 150(6):899-913. PubMed ID: 8131123
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.